Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Ridker Paul M. and MacFadyen Jean G. and Everett Brendan M. and Libby Peter and Thuren Tom and Glyn Robert J. and Kollaborációs szervezet: CANTOS Trial Group and Kastelein John and Koenig Wolfgang and Genest Jacques and Lorenzatti Alberto and Varigos John and Siostrzonek Peter and Sinnaeve Peter and Fonseca Francisco and Forster Tamás: Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
LANCET, 391 (10118). pp. 319-328. ISSN 0140-6736 (2018)

[thumbnail of Ridker.pdf]
Preview
Text
Ridker.pdf - Published Version

Download (528kB) | Preview
Creators:
Ridker Paul M.
MacFadyen Jean G.
Everett Brendan M.
Libby Peter
Thuren Tom
Glyn Robert J.
Kollaborációs szervezet: CANTOS Trial Group
Kastelein John (kollab)
Koenig Wolfgang (kollab)
Genest Jacques (kollab)
Lorenzatti Alberto (kollab)
Varigos John (kollab)
Siostrzonek Peter (kollab)
Sinnaeve Peter (kollab)
Fonseca Francisco (kollab)
Forster Tamás (kollab) MTMT
Item Type: Journal Article
Szerzők száma: 56
Journal or Publication Title: LANCET
Date: 2018
Volume: 391
Number: 10118
Page Range: pp. 319-328
ISSN: 0140-6736
Faculty/Unit: Faculty of Medicine
Institution: University of Szeged (2000-)
Language: English
MTMT rekordazonosító: 31269894
DOI azonosító: https://doi.org/10.1016/S0140-6736(17)32814-3
Date Deposited: 2022. Apr. 06. 08:57
Last Modified: 2022. Apr. 06. 08:57
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/23955
Web of Science® Times Cited: 626 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year